E 5.4565988
li 4.7125616
ĠLilly 2.1506634
Ġ& 2.1726239
ĠCo 0.3025405
's 4.8982887
ĠThird 10.966698
- 1.2080158
Qu 0.38181007
arter 0.00069506426
ĠProf 4.196765
its 0.0078231525
ĠEx 5.8442554
pected 0.8033973
Ġto 0.57085407
ĠRise 1.8347225
, 3.7797055
Ġbut 2.2509117
ĠConcern 6.842247
s 0.21998048
ĠOver 2.4899204
ĠProfit 6.8068414
ĠMarg 1.6478559
ins 0.20455042
ĠRemain 2.0045
Ġ 9.991996
Ġ 10.263102
Ċ 1.9697944
Ċ 0.046288177
E 1.7827362
li 0.017978288
ĠLilly 0.0069116666
Ġ& 0.23520333
ĠCo 0.021205612
Ġis 2.7292144
Ġexpected 0.61676335
Ġto 0.010638138
Ġreport 0.62477887
Ġhigher 2.665419
Ġthird 0.5074125
- 0.021404898
quarter 0.002181003
Ġprofits 1.1000061
Ġand 4.0967584
Ġrevenue 2.2868748
Ġwhen 1.9588562
Ġthe 1.6088862
Ġcompany 0.6033684
Ġannounces 2.2016523
Ġearnings 1.9232905
Ġon 0.812274
ĠTuesday 1.5174257
, 0.7609231
Ġaccording 2.7570546
Ġto 0.006219659
Ġanalysts 0.7208331
bytes:\xe2\x80 5.0577335
bytes:\x99 0.0031608425
Ġestimates 0.396239
Ġcompiled 1.5877547
Ġby 0.009052255
ĠBloomberg 0.60991526
. 0.16868061
ĠHowever 1.9266913
, 0.014003326
Ġconcerns 2.0585856
Ġremain 1.375033
Ġover 0.8405694
Ġnarrowing 7.600961
Ġprofit 0.16236438
Ġmargins 0.007833244
Ġfor 2.9324186
Ġthe 0.5770056
Ġpharmaceutical 2.6031842
Ġgiant 1.4631957
. 0.44374248
Ċ 0.7659712
Ċ 4.1320116e-05
L 1.9235867
illy 0.0028092572
Ġis 1.179457
Ġforecast 3.10542
Ġto 0.103301756
Ġpost 1.4415742
Ġa 1.8709056
Ġ12 4.525408
% 0.98343444
Ġincrease 0.9871151
Ġin 0.018391827
Ġearnings 2.0548275
Ġper 0.9551411
Ġshare 0.0044740574
Ġto 0.7956757
Ġ$ 0.16297959
1 0.4292572
. 0.0020965387
55 4.7484927
Ġand 2.8817737
Ġa 0.9249555
Ġ7 2.7262866
. 1.4893674
3 2.1552374
% 0.0070497766
Ġrise 0.70153534
Ġin 0.007893424
Ġrevenue 0.26413876
Ġto 0.03961634
Ġ$ 0.0126159815
5 0.9159372
. 0.027724035
43 4.812533
Ġbillion 0.0344929
, 0.88977146
Ġcompared 2.76628
Ġwith 0.4802979
Ġthe 0.57129365
Ġsame 0.6852407
Ġquarter 1.8429484
Ġlast 0.584111
Ġyear 0.0028794908
. 0.69075876
ĠOverall 5.9363127
, 0.2679112
ĠLilly 3.2076752
Ġhas 2.165749
Ġexceeded 4.1682525
Ġanalysts 0.8000934
bytes:\xe2\x80 0.08080985
bytes:\x99 0.0025734787
Ġearnings 1.5023321
Ġexpectations 1.4546937
Ġfor 1.2568444
Ġnine 3.2968514
Ġconsecutive 0.92242694
Ġquarters 0.0095464215
. 0.5849519
ĠThe 2.928555
Ġcompany 0.46263117
bytes:\xe2\x80 1.1529635
bytes:\x99 0.0004218633
s 0.00042711227
Ġshare 3.6829493
Ġprice 0.1071812
Ġis 1.792899
Ġup 0.65719396
Ġ18 4.410601
% 0.3613817
Ġso 2.0086162
Ġfar 0.00038292623
Ġthis 0.20023896
Ġyear 0.004099147
, 0.8582135
Ġoutper 3.0516021
forming 0.00080022594
Ġthe 0.21313523
ĠS 0.8463515
& 0.0011084375
P 0.00044094422
Ġ500 0.026072921
. 2.9872274
Ċ 0.22011773
Ċ 3.655083e-05
The 1.9546188
Ġexpected 5.1310353
Ġearnings 1.3911582
Ġgrowth 1.2193168
Ġis 0.974851
Ġfueled 4.1935186
Ġprimarily 3.2357755
Ġby 0.009167682
Ġhigher 3.2497547
Ġsales 0.85608196
Ġof 0.38517395
Ġnew 3.8368208
Ġproducts 2.0459886
, 0.89079
Ġincluding 0.64597195
Ġthe 1.5196949
Ġdiabetes 2.5419
Ġdrugs 3.800717
ĠJ 2.380348
ard 0.0032562169
iance 0.0019712918
Ġand 0.16738701
ĠTr 0.3574771
ul 0.0015192989
icity 0.003584392
Ġas 3.7301116
Ġwell 0.0025670838
Ġas 0.008060874
Ġthe 0.70185477
Ġcancer 2.091757
Ġtreatment 1.8095707
ĠVer 5.4906764
zen 0.0035072884
io 0.01578091
. 0.3505728
ĠTr 6.5291443
ul 0.0021813617
icity 0.003942771
Ġhas 2.7485518
Ġbeen 1.1704546
ĠLilly 3.191958
's 2.7994637
Ġfastest 2.1670146
- 0.17715696
growing 0.30576196
Ġproduct 1.0982952
Ġand 3.5791464
Ġsales 4.134929
Ġrose 4.353769
Ġover 5.117742
Ġ50 1.5327809
% 0.021840503
Ġlast 3.0247889
Ġquarter 0.20163538
Ġcompared 3.16282
Ġto 0.93390244
Ġa 2.0475411
Ġyear 0.016326029
Ġearlier 0.5752137
. 0.23506428
ĠHowever 2.8439252
, 0.0050226385
Ġrevenue 4.957882
Ġfrom 0.73552626
Ġsome 4.79033
Ġof 0.6042523
ĠLilly 0.5745245
bytes:\xe2\x80 1.063361
bytes:\x99 0.0009614214
s 0.00039234746
Ġolder 0.70277107
Ġblockbuster 3.206315
Ġdrugs 0.26389512
Ġlike 3.2208505
ĠC 3.0105147
ial 0.0010634462
is 0.0016068139
Ġand 0.6636642
ĠFort 5.614186
e 0.046741888
o 0.0018940766
Ġdeclined 2.596572
Ġdue 4.14974
Ġto 0.014628281
Ġloss 4.545107
Ġof 0.015647084
Ġpatent 0.49470612
Ġexclus 1.4338058
ivity 0.0049868147
Ġand 2.2732005
Ġcompetition 0.76580876
Ġfrom 0.3721905
Ġgeneric 1.1542349
Ġalternatives 2.3029728
. 0.061577447
Ċ 0.24697581
Ċ 2.6298881e-05
While 3.5181677
ĠLilly 1.6468307
bytes:\xe2\x80 0.952692
bytes:\x99 0.0008390627
s 0.00064812513
Ġtop 3.2535925
- 0.7066241
line 0.14904158
Ġresults 3.5435762
Ġhave 2.0865822
Ġbeen 0.66205746
Ġsolid 2.5294425
, 0.3261379
Ġprofit 2.6446643
Ġmargins 0.044763844
Ġhave 0.31975374
Ġbeen 0.7701857
Ġunder 2.3263881
Ġpressure 0.062057875
Ġdue 1.5077863
Ġto 0.02517834
Ġhigher 2.3101108
Ġcosts 1.9055358
. 3.2581298
ĠThe 1.35785
Ġcompany 0.17139623
Ġhas 1.4313072
Ġinvested 3.8787794
Ġheavily 0.705403
Ġin 0.21596497
Ġresearch 1.009716
Ġand 0.10748291
Ġdevelopment 0.045930285
Ġto 1.4873081
Ġrest 8.1918745
ock 0.36092636
Ġits 0.099876545
Ġproduct 2.5701025
Ġpipeline 0.06957346
Ġas 3.0150893
Ġwell 1.217311
Ġas 0.008689158
Ġin 1.4430175
Ġmarketing 1.4478091
Ġand 1.3568257
Ġpromotions 4.427305
Ġto 0.7167652
Ġdrive 2.9111242
Ġsales 0.50554436
Ġof 0.71671546
Ġnew 0.975889
Ġdrugs 1.0295143
. 0.14303741
ĠLilly 2.1951668
bytes:\xe2\x80 1.2088143
bytes:\x99 0.00038626595
s 0.00019404522
Ġoperating 1.3459288
Ġmargin 1.3289084
Ġdeclined 2.3945181
Ġto 0.5671627
Ġ21 3.38311
% 1.2398415
Ġlast 1.5189008
Ġquarter 0.059123058
Ġfrom 0.4926581
Ġ24 1.7119465
% 0.2064753
Ġa 0.6165215
Ġyear 0.0009774667
Ġago 1.6041408
. 0.3917019
Ċ 0.66350347
Ċ 1.2351458e-05
Looking 5.1678205
Ġahead 0.2415817
, 0.064864054
ĠLilly 0.5613095
Ġaims 6.6357093
Ġto 0.009155953
Ġlaunch 2.9745905
Ġ20 5.573815
Ġnew 0.76730627
Ġproducts 0.8266346
Ġbetween 2.1102412
Ġ2018 1.8758914
Ġand 0.02811342
Ġ20 2.3461921
23 0.049910694
Ġto 2.880763
Ġdrive 2.7481625
Ġfuture 1.6460499
Ġgrowth 0.40811536
. 0.19890767
Ġ" 5.3514037
We 0.90945995
Ġremain 3.7509277
Ġconfident 1.8618422
Ġin 0.39681002
Ġour 0.4129634
Ġlong 2.2492206
- 0.013452098
term 0.023374677
Ġoutlook 2.4517927
, 1.5216271
bytes:\xe2\x80 1.620265
bytes:\x9d 0.0024903577
Ġsaid 0.9997077
ĠChief 1.8600758
ĠExecutive 0.57485616
ĠDavid 2.384581
ĠR 0.061329618
icks 0.0019173673
Ġin 1.0777811
ĠLilly 5.499775
bytes:\xe2\x80 0.4591501
bytes:\x99 0.00026624158
s 0.00043188062
Ġsecond 1.8148412
- 0.051515043
quarter 0.00079312886
Ġearnings 0.23022391
Ġcall 0.64362305
. 0.37379348
ĠHowever 4.016352
, 0.003338805
Ġthe 2.018695
Ġcost 6.8753557
Ġto 2.330094
Ġdevelop 1.0033448
Ġnew 1.0073804
Ġdrugs 0.5266597
Ġand 1.9524652
Ġgain 4.770726
Ġregulatory 0.5528659
Ġapproval 0.5762427
Ġremains 2.1125906
Ġextremely 4.6630864
Ġhigh 0.16078971
Ġand 1.8294281
Ġuncertain 4.229499
. 0.49102718
Ċ 1.0430748
Ċ 2.8326363e-05
L 1.9834477
illy 0.0087594455
Ġfaces 3.4716527
Ġnumerous 5.2108984
Ġnear 5.175605
- 0.015278316
term 0.03449333
Ġchallenges 0.587078
, 1.1851885
Ġincluding 0.28448865
Ġpatent 3.4499013
Ġexp 0.36322436
ir 0.20864214
ations 9.103483e-05
, 2.753432
Ġpricing 3.013485
Ġpressures 0.77846414
Ġin 3.3387465
Ġthe 0.83631027
ĠU 0.5144675
. 6.778445e-05
S 0.0024556427
. 0.2620629
Ġmarket 1.6481636
, 0.7196722
Ġand 0.5773898
Ġcompetitive 5.386371
Ġthreats 0.59181136
Ġfrom 0.4128747
Ġrival 4.1413226
Ġdrug 1.0096495
makers 0.39807892
. 0.43416986
ĠWhile 4.0247855
ĠLilly 1.4941802
bytes:\xe2\x80 1.1526136
bytes:\x99 0.00069208303
s 0.00026373632
Ġinnovation 6.565341
- 4.684801
driven 0.89872026
Ġgrowth 1.677545
Ġstrategy 0.41603842
Ġhas 1.2770158
Ġstarted 5.7577014
Ġto 0.19307011
Ġpay 0.67217475
Ġoff 0.04657464
, 0.43802595
Ġinvestors 2.071909
Ġwill 0.59239894
Ġbe 0.78550225
Ġclosely 1.0063479
Ġmonitoring 1.5860543
Ġthe 0.72093916
Ġcompany 0.22256516
bytes:\xe2\x80 0.13252221
bytes:\x99 6.468596e-05
s 0.00016411634
Ġmargins 3.285302
Ġand 1.3496169
Ġpipeline 4.105861
Ġprogress 1.6649597
Ġto 1.7620063
Ġensure 3.2133036
Ġsustainable 2.1680465
Ġmomentum 6.6005
Ġin 1.9552833
Ġthe 0.23723081
Ġcoming 2.4529433
Ġquarters 0.27059644
. 0.15325642
